Skip to main content
. 2014 Apr 28;48(2):100–107. doi: 10.4132/KoreanJPathol.2014.48.2.100

Table 4.

Recent studies examining the relationship between survival outcomes and KRAS mutation in non-small cell lung cancer

graphic file with name kjpathol-48-100-i004.jpg

DS, direct sequencing; EGFR-TKI, epidermal growth factor receptor tyrosine kinase inhibitor; RFLP, restriction fragment length polymorphism.